Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Futura Surgicare is an Indian medtech manufacturer focused on wound closure products, hernia repair solutions, and related surgical consumables and devices. Founded in 1994 and headquartered in Bengaluru, the company is best known for its Dolphin-branded portfolio, including sutures, meshes, and staplers. It serves hospitals, distributors, and OEM/private-label customers, with exports to more than 85 countries. The business emphasizes cost-effective surgical products backed by quality systems such as ISO 13485, CE Mark, WHO GMP, and CDSCO compliance. In 2024, the company received a $25 million investment from Jashvik Capital to support growth and expansion across specialty device and consumables categories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Futura Surgicare.